Manufacturer country License holder. KRKA d.d., Novo mesto, Smarjeska cesta 6, 8501 Novo Mesto
|
|
- Nicholas Matthews
- 6 years ago
- Views:
Transcription
1 List of the medicines recommended for registration by N 12-1/15 meeting decision of the Pharmacological Council of MoH of A dated on December 04, 2015 President E. Amroyan N Trade name International nonproprietary (generic) names or names of active substances dosage form dosage strength & output form (packaging) Manufacturer country License holder License holder country Prescription status Conclusion N & date 1. Cordipin XL nifedipine modifiedrelease 40mg; (30/3x10/) in KKA d.d., Novo mesto, Smarjeska cesta 6, 8501 Novo Mesto KKA d.d., Novo mesto, Smarjeska cesta 6, 8501 Novo Mesto Pantogam hopantenic acid (calcium hopantenate) 250mg; (50/5x10/) in PIQ-PHAMA LEK LLC, 46g, Beryozovaya str., Severnyj-Pervyj town, Belgorod district, Belgorod region, ussia "PIQ-PHAMA" LLC, , pereulok Oruzheyniy, 25, building 1, Moscow ussia inger sodium chloride, potassium chloride, calcium chloride (calcium chloride dihydrate) 8,6mg/ml+0,3mg/ ml+0,33mg/ml; 100ml, 200ml, 250ml, 500ml, 1000ml, 2000ml, 3000ml plastic pack Yerevan, affi epublic of 0064, Yerevan, affi epublic of Sodium chloride solution 0.9% sodium chloride 9mg/ml; 50ml, 100ml, 200ml, 250ml, 400ml, 500ml, 1000ml, 2000ml, 3000ml Yerevan, affi epublic of 0064, Yerevan, affi epublic of
2 5. Lespefril lespedeza bicolor solution oral 708mg/ml; 100ml glass or plastic bottle VIFITEH CJSC, SCAM, Obolensk v., corp. 84, corp. 87, build. 90, Serpukhov district, Moscow region, ussia VIFITEH CJSC, SCAM, Obolensk v., Serpukhov district, Moscow region, ussia Persen valeriana officinalis extract, melissa officinalis extract, mentha piperita extract coated 35mg+17,5mg+17,5mg; (40/4x10/), in Lek Pharmaceuticals d.d., Verovskova Str. 57, 1526 Ljubljana- bulk manufacturer, batch releaser, Lek Pharmaceuticals d.d.,trimlini 2D, Lendava, 9220, primary and secondary Lek Pharmaceuticals d.d., Verovskova Str. 57, 1526 Ljubljana, Neuromultivit vitamin B1, vitamin B6, vitamin B12 100mg+200mg+0, 2mg; (20/1x20/) in, (100/5x20/), in G.L. Pharma GmbH, Schlossplatz 1, 8502 Lannach -batch releaser, G.L. Pharma GmbH, Industriestrasse 1, 8502 Lannach, Austria -bulk manufacturer, Austria VALEANT LLC, Shabolovka st. 31, building 5, , Moscow ussia Tritace ramipril 5mg; (28/2x14.) in Sanofi-Aventis S.p.A., Strada Statale N17- km22, Scoppito Sanofi-Aventis Deutschland GmbH, D Frankfurt am Main Tritace ramipril 10mg; (28/2x14/) in Sanofi-Aventis S.p.A., Strada Statale N17- km22, Scoppito Sanofi-Aventis Deutschland GmbH, D Frankfurt am Main Tritace ramipril 2,5mg; (28/2x14.) in Sanofi-Aventis S.p.A., Strada Statale N17- km22, Scoppito Sanofi-Aventis Deutschland GmbH, D Frankfurt am Main
3 11 Warfarin warfarin (warfarin sodium) 2,5mg; (40/2x20/), in, (100/5x20/), in Belmedpreparaty UE, , Minsk, Fabritsius St., 30 Belmedpreparaty UE, , Minsk, Fabritsius St., Polyglucin- PharmaTech dextran 70 60mg/ml; 100ml, 200ml, 250ml, 400ml, 500ml Yerevan, affi epublic of 0064, Yerevan, affi epublic of Iono-Tech sodium acetate (sodium acetate trihydrate), sodium chloride, potassium chloride, calcium chloride (calcium chloride dihydrate), magnesium chloride (magnesium chloride hexahydrate) 5mg/ml+5,85mg/ ml+0,302mg/ml+ 0,36mg/ml+0,25m g/ml; 50ml, 100ml, 200ml, 250ml, 400ml, 500ml, 1000ml Yerevan, affi epublic of 0064, Yerevan, affi epublic of heopolyglu- cin-pharma- Tech dextran mg/ml; 100ml, 200ml, 250ml, 400ml, 500ml Yerevan, affi epublic of 0064, Yerevan, affi epublic of Spasmomen otilonium bromide 40mg; (30/2x15/) in, (30/3x10/), in Berlin-Chemie A.G.,Glienicker Weg 125, D Berlin-batch releaser, Berlin- Chemie A.G., Tempelhofer Weg 83, D Berlin,bulk manufacturer A. Menarini Industrie Farmaceutiche iunite S.r.l., Via Sette Santi, Firenze Encifer Iron sucrose complex i/v 20mg/ml; (5) ampoules 5ml Emcure Pharmaceuticals Ltd., Plot NO. J-174, J- 168, J-168/1, MIDC, Tarapur, Boisar, Thane Emcure Pharmaceuticals Ltd., T-184, M.I.D.C., Bhosari, Pune
4 401506, Maharashtra State , Maharashtra 17 Unigamma benfotiamine, pyridoxine (pyridoxine, cyanocobalamin 100mg+100mg+2 00mcg; (30/1x30/), in Unipharm Inc., 75 Progress Lane, Waterbury, Connecticut (CT), USA Unipharm Inc., 350, 5th avenue, suite 6701, New York, USA Advantan methylprednisolone (methylprednisolon e aceponate) emulsion for external use 1mg/g; 20g aluminium laminated tube Bayer Healthcare Manufacturing S.r.l., Via E. Schering 21, Segrate (Milano) Bayer Pharma AG, Mullerstrasse 178, 13353, Berlin Pregabalin Canon 75mg; (14/2x7/), in, Zarechnaya str Moskow region, Schelkovo ussia Zarechnaya str Moskow region, Schelkovo ussia Pregabalin Canon 150mg; (14/2x7/), in, Zarechnaya str Moskow region, Schelkovo ussia Zarechnaya str Moskow region, Schelkovo ussia Pregabalin Canon 300mg; (14/2x7/), in, Zarechnaya str Moskow region, Schelkovo ussia Zarechnaya str Moskow region, Schelkovo ussia Pregabalin- ichter 75mg; (14/1x14/) in, (56/4x14) in Gedeon ichter-us CJSC, Lesnaya st. 40, Shuvoye, Moscow region, Yegoriyevsky district, ussia Gedeon ichter PLC, Pregabalin- ichter 150mg;, Gedeon ichter-us CJSC, Lesnaya st. 40, Shuvoye, Moscow region, ussia Gedeon ichter PLC,
5 (56/4x14/), in Yegoriyevsky district, Pregabalin- ichter 300mg;, (56/4x14/), in Gedeon ichter-us CJSC, Lesnaya st. 40, Shuvoye, Moscow region, Yegoriyevsky district, ussia Gedeon ichter PLC, Nonpres eplerenone 50mg; (20/2x10/), in Pharmaceutical Works Polfa in Pabianice JSC, 5 Marszalka J. Pilsudskiego Str., Pabianice Pharmaceutical Works Polfa in Pabianice JSC, 5 Marszalka J. Pilsudskiego Str., Pabianice Nonpres eplerenone 25mg; (20/2x10/), in Pharmaceutical Works Polfa in Pabianice JSC, 5 Marszalka J. Pilsudskiego Str., Pabianice Pharmaceutical Works Polfa in Pabianice JSC, 5 Marszalka J. Pilsudskiego Str., Pabianice Gemcitabine (gemcitabine gemcitabine powder lyophilized for 200mg; (1) glass vial 10ml Belmedpreparaty UE, , Minsk, Fabritsius St., 30 Belmedpreparaty UE, , Minsk, Fabritsius St., Gemcitabine (gemcitabine gemcitabine powder lyophilized for 1000mg; (1) glass vial 50ml Belmedpreparaty UE, , Minsk, Fabritsius St., 30 Belmedpreparaty UE, , Minsk, Fabritsius St., Oftagel carbomer 974P gel eye 2,5mg/g; plastic vial-dropper 10g Santen Oy, Niittyhaankatu 20, Tampere-batch releaser, Ursapharm Arzneimittel GmbH, Industriestrasse 35, Saarbrucken, -bulk Finland Santen Oy, Niittyhaankatu 20, Tampere Finland
6 and secondary 30 Tlocin-0,4 tamsulosin (tamsulosin modifiedrelease, hard 0,4mg; (30/3x10/), in Zim Laboratories Ltd., B- 21/22, MIDC Area, Kalmeshwar , Dist. Nagpur (M.S.) Zim Laboratories Ltd., Ground Floor, Sadoday Gyan, Nelson Square, Chhindwara oad, Nagpur Mexicam meloxicam, lidocaine (lidocaine i/m 5mg/ml+3mg/ml; (6) ampoules 3ml Delta Pharma, Industrial Zone B4,10th of amadan city Egypt Delta Pharma, Industrial Zone B4,10th of amadan city Egypt Cavinton vinpocetine 5mg/ml; (10/2x5/) ampoules 2ml, in plastic tray Gedeon ichter PLC, 1103 Gedeon ichter PLC, Cavinton vinpocetine 5mg/ml; (10/2x5/) ampoules 5ml in plastic tray Gedeon ichter PLC, 1103 Gedeon ichter PLC, Cavinton Forte vinpocetine 10mg; (30/2x15/) in, (90/6x15/) in Gedeon ichter PLC, 1103 Gedeon ichter PLC, Cavinton vinpocetine 5mg; (50/2x25/), in Gedeon ichter PLC, 1103 Gedeon ichter PLC, Naphthyzin- Arsanit-S naphazoline drops nasal 0.5mg/ml; 10ml glass vial Yerevanyan str., Masisbatch releaser, secondary, PharmaTech CJSC, 111 affi str., 0064, Yerevan, epublic of -bulk epublic of Yerevanyan str., Masis epublic of
7 37 Naphthyzin- Arsanit-S naphazoline drops nasal 1mg/ml; 10ml glass vial Yerevanyan str., Masisbatch releaser, secondary, PharmaTech CJSC, 111 affi str., 0064, Yerevan, epublic of -bulk epublic of Yerevanyan str., Masis epublic of Naphthyzin- Arsanit naphazoline spray nasal 1mg/ml; 10ml glass or plastic vial and dispenser Yerevanyan str., Masisbatch releaser, secondary, PharmaTech CJSC, 111 affi str., 0064, Yerevan, epublic of -bulk epublic of Yerevanyan str., Masis epublic of
str., 0064, Yerevan, Republic of Armenia-bulk manufacturer GM Pharmaceuticals Ltd, PSP group 65, Qvemo Phonichala str., Tbilisi
List of the medicines recommended for registration by N 12-2/15 meeting decision of the Pharmacological Council of MoH of A dated on December 18, 2015 President E. Amroyan N Trade name International nonproprietary
More informationList of the medicines recommended for registration by N 6-1/16 meeting decision of the Pharmacological Council of MoH of RA dated on June 10, 2016
List of the medicines recommended for registration by N 6-1/16 meeting decision of the Pharmacological Council of MoH of A dated on June 10, 2016 President E. Amroyan N Trade name International nonproprietary
More informationFamar Lyon, 29 Avenue Charles de Gaulle, Saint Genis Laval. PharmaTech CJSC, 0064, Yerevan, Raffi str. 111
List of the medicines recommended for registration by N 9-1/15 meeting decision of the Pharmacological Council of MoH of A dated on September 18, 2015 President E. Amroyan N Trade name International nonproprietary
More informationList of the medicines recommended for registration by N 10-1/17 meeting decision of the Pharmacological Council of MoH of RA dated on October 13, 2017
List of the medicines recommended for registration by N 10-1/17 meeting decision of the Pharmacological Council of MoH of A dated on October 13, 2017 President E. Amroyan N Trade name International nonproprietary
More informationEgis Pharmaceuticals PLC, 9900, Kormend, Matyas Kiraly u. 65. Egis Pharmaceuticals PLC, 1165 Budapest, Bokenyfoldi st
List of the medicines recommended for registration by N 9-1/16 meeting decision of the Pharmacological Council of MoH of A dated on September 02, 2016 President E. Amroyan N Trade name International nonproprietary
More informationLekpharm JLLC, , Minskaya region, Logoysk, Minskaya str. 2a. Lekpharm JLLC, , Minskaya region, Logoysk, Minskaya str.
List of the medicines recommended for registration by N 11-2/18 meeting decision of the Pharmacological Council of MoH of A dated on November 30, 2018 President E. Amroya N Trade name International nonproprietary
More informationList of the medicines recommended for registration by N 6-1/18 meeting decision of the Pharmacological Council of MoH of RA dated on June 15, 2018
List of the medicines recommended for registration by N 6-1/18 meeting decision of the Pharmacological Council of MoH of A dated on June 15, 2018 President E. Amroya N Trade name International nonproprietary
More informationList of the medicines recommended for registration by N 5-1/16 meeting decision of the Pharmacological Council of MoH of RA dated on May 13, 2016
List of the medicines recommended for registration by N 5-1/16 meeting decision of the Pharmacological Council of MoH of A dated on May 13, 2016 President E. Amroyan N Trade name International non-proprietary
More informationList of the medicines recommended for registration by N 5-2/16 meeting decision of the Pharmacological Council of MoH of RA dated on May 27, 2016
List of the medicines recommended for registration by N 5-2/16 meeting decision of the Pharmacological Council of MoH of A dated on May 27, 2016 President E. Amroyan N Trade name International nonproprietary
More informationList of the medicines recommended for registration by N 8-1/18 meeting decision of the Pharmacological Council of MoH of RA dated on August 17, 2018
List of the medicines recommended for registration by N 8-1/18 meeting decision of the Pharmacological Council of MoH of A dated on August 17, 2018 President E. Amroya N Trade name International nonproprietary
More informationLegal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS
Legal Supplement Part B Vol. 57, No. 6 18th January, 2018 11 LEGAL NOTICE NO. 5 REPUBLIC OF TRINIDAD AND TOBAGO FOOD AND DRUGS ACT, CHAP. 30:01 NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS ISSUED
More informationList of the medicines recommended for registration by N 3-1/16 meeting decision of the Pharmacological Council of MoH of RA dated on March 18, 2016
List of the medicines recommended for registration by N 3-1/16 meeting decision of the Pharmacological Council of MoH of A dated on March 18, 2016 President E. Amroyan N Trade name International nonproprietary
More informationList of the medicines recommended for registration by N 10-1/16 meeting decision of the Pharmacological Council of MoH of RA dated on October 07, 2016
List of the medicines recommended for registration by N 10-1/16 meeting decision of the Pharmacological Council of MoH of A dated on October 07, 2016 President E. Amroyan N Trade name International nonproprietary
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE
More informationMember State Marketing autorisation Holder Invented Name Strength Pharmaceutical form Route of administration
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1 Member State Marketing autorisation Holder
More informationList of the medicines recommended for registration by N 5-2/15 meeting decision of the Pharmacological Council of MoH of RA dated on May 29, 2015
List medicines recommended for registration by N 5-2/15 meeting decision Pharmacological ouncil MoH A dated on May 29, 2015 President E. Amroyan N Trade name International nonproprietary (generic) names
More informationWHOPAR part 5 Suppliers submission of the SRA approved text
PARTICULARS TO APPEAR ON THE OUTER PACKAGING ΒΟΧ x 1 plastic ampoule x 2ml [4ml] 1. NAME OF THE MEDICINAL PRODUCT Ζophralen Ondansetron 2. STATEMENT OF ACTIVE SUBSTANCE(S) Each 2ml [4ml] plastic ampoule
More informationList Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities)
Edition: Version 11-19th of July 2018 List of A & B Products List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) As from the version
More informationLIST OF REGISTRED DRUGS IN ARMENIA ( )
LIST OF REGISTRED DRUGS IN ARMENIA (01.08.2017-31.08.2017) N Trade name International nonproprietary name (generic) or active ingredients name Drug form Dose and packaging Manufacturer Country ATC 1 code
More informationIraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001
nam origmanufacturer nammanufacturer National code Mousel Scientific Iraq NDI Iraq 04-J00-042 Sandoz GmbH Austria for Sandoz GmbH by Sandoz Ilac Sanayi ve India 05-AH0-040 France Famar Lyon France 05-D00-024
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406
More informationArtesunate 60 mg for injection WHOPAR part 5 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 LABELLING
LABELLING 1 PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton (pack of 1 vial and 2 ampoules) 1. NAME OF THE MEDICINAL PRODUCT Artesun * 2. STATEMENT OF ACTIVE SUBSTANCE Each vial contains 60 mg artesunate
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DUPHALYTE Solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Composition per ml VITAMINS
More informationCopy of the mail received from the Vietnamese company
Copy of the mail received from the Vietnamese company Firstly I would like to give you some basic information about us: 1/Who we are: Lang Son medical equipment and pharmaceutical joint-stock Company 168
More informationPROFESSIONAL INFORMATION
This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled (Complementary medicine) PROPRIETARY NAME AND DOSAGE FORM: BEROCCA
More informationCalgary Long Term Care Formulary
Page 1 of 10 Calgary Long Term Care Formulary Pharmacy & Therapeutics November 2018 Highlights https://www.albertahealthservices.ca/info/page4071.aspx Page 2 of 10 Contents November 2018... 3 Formulary
More informationPROFESSIONAL INFORMATION
This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled: Complementary Medicine PROPRIETARY NAME AND DOSAGE FORM: BEROCCA
More informationArtesunate 120mg powder for injection (Guilin Pharmaceutical Co., Ltd), MA90 LABELLING. Page 1 of 6
LABELLING Page 1 of 6 PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer Carton 1. NAME OF THE MEDICINAL PRODUCT Artesun 120mg * 2. STATEMENT OF ACTIVE SUBSTANCE Each vial contains 120 mg artesunate powder
More informationAdvance Notification of Amendments to the December 2018 Drug Tariff
Advance Notification of Amendments to the December 2018 Drug Tariff ADDITIONS Zero Discount Fondaparinux sodium solution for injection pre-filled (ALL) FreeStyle Libre Sensor Oxygen CD cylinder Oxygen
More information(Invented) Name Strength Pharmaceutical Form. 3 mg/3 ml Solution for injection. Kytril 2 mg - Filmtabletten 2 mg Film-coated tablet Oral use
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1 Austria Austria Bulgaria Bulgaria
More informationStatus of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex,
More informationPackage leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin
Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution Levofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage leaflet: Information for the user. multibic potassium-free solution for haemodialysis/haemofiltration
Package leaflet: Information for the user multibic potassium-free solution for haemodialysis/haemofiltration Read all of this leaflet carefully before you start using this medicine because it contains
More informationAlvizia Healthcare Private Limited
+91-8048413356 Alvizia Healthcare Private Limited https://www.alviziahealthcare.net/ We are one of the leading manufacturers, wholesaler and traders of the Pharmaceutical Products. Owing to their rich
More information(Invented) Name Strength Pharmaceutical form. Effortil comp. - Tropfen 2 mg/ml, 10 mg/ml. 2.5 mg prolonged-release capsule, hard
Annex I List of the names, pharmaceutical (s), strength(s) of the medicinal product(s), route(s) of, marketing authorisation holder(s) in the member states 1 Boehringer Ingelheim RCV GmbH & Co KG, Dr.
More informationSubject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application
More information(Invented) Name Strength Pharmaceutical form. Ergotop 10 mg - Tabletten. Ergotop 20 mg - Filmtabletten. Ergotop 30 mg - Filmtabletten
Annex I List of the names, pharmaceutical (s), strength(s) of the medicinal product(s), route(s) of, marketing authorisation holder(s) in the member states 1 Bulgaria Bulgaria Czech Republic Kwizda Pharma
More informationPharmaceutical. Injection/Concentrate. 25ml Vial , ml Vial Injection/Solution for 2ml Ampoule x
1 ANZATAX 300mg/50ml (Multi Dose) m Injection/Concentrate 2 ANZATAX 150mg/25ml Infusion/Concentrate 3 ABRAXANE 100mg Injection/Suspension 4 ANZATAX 30mg/5ml Infusion/Concentrate 5 MEDACEF 500mg Capsules
More informationAdvance Notification of Amendments to the March 2017 Drug Tariff
Advance Notification of Amendments to the March 2017 Drug Tariff ADDITIONS Part I - Drugs And Preparations Special Container Drug Qty Price Acetylcysteine 600mg capsules 30 39.95 A Caffeine citrate 50mg/5ml
More informationTAFEN NASAL 50mcg nasal spray, suspension
PACKAGE LEAFLET: INFORMATION FOR THE USER TAFEN NASAL 50mcg nasal spray, suspension BUDESONIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationTable updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product
More informationOLFEMY CARE (DIVISION OF VENTUS PHARMACEUTICAL PVT LTD) (ISO 9001: 2008 CERTIFIED COMPANY)
OLFEMY CARE (DIVISION OF VENTUS PHARMACEUTICAL PVT LTD) (ISO 9001: 2008 CERTIFIED COMPANY) SCF-320 GROUND FLOOR AND BASEMENT MM- MANIMAJRA, CHANDIGARH-160101, CONTACT NO:9216504338, 9915757530 E-MAIL US
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP FeLV lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationPackage leaflet: Information for the user. Carmellose sodium
Package leaflet: Information for the user CELLUVISC 0.5% w/v, eye drops, solution, unit dose Carmellose sodium Read all of this leaflet carefully before you start using this medicine because it contains
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Proteq West Nile suspension for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax Rabies suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
More informationPackage leaflet: Information for the user. Atosiban SUN 37.5 mg/5 ml concentrate for solution for infusion atosiban
Package leaflet: Information for the user Atosiban SUN 37.5 mg/5 ml concentrate for solution for infusion atosiban Read all of this leaflet carefully before you are given this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
a Novartis Company PACKAGE LEAFLET: INFORMATION FOR THE USER Pantoprazole Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to read it again. -
More informationOTCPharm H1/Q2 sales results
OTCPharm H1/Q2 sales results Olga Mednikova, CEO Irina Bakhturina, Head of Investor Relations August, 2014 5 Jul 2013 Pharmstandard BoD convened two Extraordinary Shareholders Meetings ( ESMs ) on spin-off
More informationSCIENTIFIC DISCUSSION
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More informationOtodex Framycetin sulfate (fra-me-see-tin sul-fate), Gramicidin (grammy-sigh-din), Dexamethasone (dex-ar-meth-arsone)
Otodex Framycetin sulfate (fra-me-see-tin sul-fate), Gramicidin (grammy-sigh-din), Dexamethasone (dex-ar-meth-arsone) Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some
More informationPublic Assessment Report Scientific discussion. Ciprofloxacin Accord (ciprofloxacin hydrochloride) SE/H/1026/01-03/DC
Public Assessment Report Scientific discussion Ciprofloxacin Accord (ciprofloxacin hydrochloride) SE/H/1026/01-03/DC This module reflects the scientific discussion for the approval of Ciprofloxacin Accord.
More informationThis indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye.
Page 1 of 5 SCHEDULING STATUS Schedule 0 PROPRIETARY NAME AND DOSAGE FORM REFRESH LIQUIGEL COMPOSITION REFRESH LIQUIGEL lubricant eye drops contain carboxymethylcellulose sodium 10 mg/ml. Preservative:
More informationMYCAMINE National Drug Code Directory
0469-3250-10 MYCAMINE National Drug Code Directory The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs
More informationHardness (Total & Calcium) Test Kit TK4040-Z 1 drop = 2 or 10 ppm as CaCO 3
Hardness (Total & Calcium) Test Kit 1 drop = 2 or 10 ppm as CaCO 3 / 25 ml blue caps KIT COMPONENTS: ED2073-B Hardness Titrant Low, 60 ml ED2070-B Hardness Titrant High, 60 ml HA7405-A Hardness Buffer
More informationFlavour: Red fruits, peach and passion fruit, orange, lime and grapefruit Package size: 1.7g Pharmaceutical form: Powder
Flavour: Red fruits, peach and passion fruit, orange, lime and grapefruit Package size: 1.7g Pharmaceutical form: Powder Isotonic sports drink with added vitamins Energy Mineral is a multipurpose isotonic
More informationCopenhagen, Denmark September 2014
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active pharmaceutical ingredients 1 Priorities for Product Development
More informationUPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:
1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic bottle 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic Bottle 3 0.9 Sodium Chloride with 5% Dextrose 1000 ml in plastic bottle
More informationComparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity
Supporting information Volume 72 (2016) Supporting information for article: Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity Gwen E. Owens, Danielle M. New, Alejandra
More informationLIST OF REGISTRED DRUGS IN ARMENIA ( )
LIST OF REGISTRED DRUGS IN ARMENIA (01.01.2016-31.01.2016) N Trade name International nonproprietary name (generic) or active ingredients name Drug form Dose and packaging Manufacturer Country ATC 1 code
More informationTHE DOSING SPECIALIST
04 THE DOSING SPECIALIST THE COMPANY WHO ARE WE? Over the past 30 years, ROVIPHARM has become the specialist manufacturer of medical and dosing devices for the pharmaceutical and healthcare industries.
More informationAdvance Notification of Amendments to the November 2017 Drug Tariff
Advance Notification of Amendments to the November 2017 Drug Tariff ADDITIONS Pyridostigmine bromide 180mg modified-release capsules Special Container * This pack only (others already listed) Drug Qty
More informationAdvance Notification of Amendments to the August 2018 Drug Tariff
Advance Notification of Amendments to the August 2018 Drug Tariff ADDITIONS Zero Discount Brivaracetam 100mg tablets Brivaracetam 25mg tablets Brivaracetam 50mg tablets Brivaracetam 75mg tablets Maraviroc
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ALBUNORM 20% 200 g/l, Solution for infusion Human albumin
PACKAGE LEAFLET: INFORMATION FOR THE USER ALBUNORM 20% 200 g/l, Solution for infusion Human albumin Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:
More informationRead all of this leaflet carefully before you start using this medicine.
PACKAGE LEAFLET: INFORMATION FOR THE USER Allergo-COMOD nasal spray 20 mg/ml Nasal spray, solution Active ingredient: sodium cromoglicate (Ph. Eur.) 1 spray of 0.14 ml of Allergo-COMOD nasal spray contains
More informationMarketing authorisations granted in September 2012
PL 00037/0648 03/09/2012 ABBOTT LABORATORIES LIMITED LEVELANZ 250 MG FILM-COATED TABLETS LEVETIRACETAM 250 MILLIGRAMMES POM PL 00037/0649 03/09/2012 ABBOTT LABORATORIES LIMITED LEVELANZ 500 MG FILM-COATED
More informationNPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,
What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED
More informationTable updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 26 th February 2019 Product
More informationPEDIATRIC INFUVITE MULTIPLE VITAMINS FOR INFUSION National Drug Code Directory
54643-5646-0 PEDIATRIC INFUVITE MULTIPLE VITAMINS FOR INFUSION National Drug Code Directory The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration
More informationPublic Assessment Report. Scientific discussion
Public Assessment Report Scientific discussion Valbanatan 320 mg/25 mg; 160 mg/12,5 mg; 160 mg/25 mg; 320 mg/12,5 mg; 320 mg/25 mg Filmtabletten Valbacomp 320 mg/25 mg; 160 mg/12,5 mg; 160 mg/25 mg; 320
More informationO-CAL FA MULTIVITAMIN National Drug Code Directory
0813-9616-01 O-CAL FA MULTIVITAMIN National Drug Code Directory The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes
30 June 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October
More informationJSC «Olainfarm», Latvia PAS-Na 5.52 g Powder for oral solutions
PAminosalicylic acid (as sodium salt) PASNa 5.52 g PARTICULARS TO APPEAR ON THE OUTER PACKAGING (LABEL) 1. NAME OF THE MEDICINAL PRODUCT paminosalicylate sodium NATRII AMINOSALICYLAS DIHYDRICUS 2. STATEMENT
More informationPackage leaflet: Information for the patient
Package leaflet: Information for the patient KLORUR NATRIUMI Solution for injection 1000 mg / 10 ml (10 %) Solution for injection 85 mg / 10 ml (0.85 %) Solution for infusion 0.9% (Sodium chloride) Read
More informationAnnexure III SOLUTIONS AND REAGENTS
Annexure III SOLUTIONS AND REAGENTS A. STOCK SOLUTIONS FOR DNA ISOLATION 0.5M Ethylene-diamine tetra acetic acid (EDTA) (ph=8.0) 1M Tris-Cl (ph=8.0) 5M NaCl solution Red cell lysis buffer (10X) White cell
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RHINISENG suspension for injection for pigs. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:
More informationDIANEAL LOW CALCIUM WITH DEXTROSE National Drug Code Directory
0941-0459-08 DIANEAL LOW CALCIUM WITH DEXTROSE The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured,
More informationTENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014
28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some
More informationPARENTERAL PREPARATIONS
PARENTERAL PREPARATIONS INTRODUCTION Parenteral (Gk, para enteron, beside the intestine) dosage forms differ from all other drug dosage forms, because they are injected directly into body tissue through
More information2019 Catalog Hospital and Ophthalmology Products and Services
209 Catalog Hospital and Ophthalmology Products and Services Ophthalmology Ophthalmology Services. No prescription required No minimum order quantity New formulations are continually added to our portfolio.
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ingelvac CircoFLEX suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose (1 ml)
More informationWhat Is. Is the combination of two or more things to produce something that neither component could produce alone.
What Is Is the combination of two or more things to produce something that neither component could produce alone. 1 Our Skills Synergy Swiss Pharma has an experienced team with collective knowledge and
More informationDUAL CHAMBER SYSTEMS
DUAL CHAMBER SYSTEMS HEALTH is the inestimable value to which Pharmaceutical Industry is committed. BORMIOLI PHARMA contributes to this mission by following the same values that guide this industry: quality,
More informationCATALOGUE OF MEDICAL DEVICES AND MEDICINAL PRODUCTS
20 17 CATALOGUE OF MEDICAL DEVICES AND MEDICINAL PRODUCTS PARACÉLSIA - Indústria Farmacêutica, S.A. is a pharmaceutical company founded in 1930, exclusively owned by private capitals. We have been manufacturing
More informationREDERGIN 1.5 mg tablets; 4.5 mg tablets; 1 mg/ml oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER REDERGIN 1.5 mg tablets; 4.5 mg tablets; 1 mg/ml oral solution ERGOLOID MESYLATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More informationKern Pharma Portfolio 2014
Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN
More informationEnforcement Report - Week of August 15, 2018
Enforcement Report - Week of August 15, 2018 77850 07/25/2018 08/09/2018 Mylan Pharmaceuticals Inc. 781 Chestnut Ridge Rd Morgantown WV United States U.S. Nationwide Dymista (azelastine hydrochloride and
More informationPRIMAXIN National Drug Code Directory
0006-3516-59 PRIMAXIN National Drug Code Directory The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs
More informationRelease of the 2013/14 Invitation to Tender
07 November 2013 Release of the 2013/14 Invitation to Tender The 2013/14 Invitation to Tender (2013/14 ITT) has been distributed today via the electronic tender (etender) system. If you do not receive
More informationCalgary Long Term Care Formulary
Page 1 of 14 Calgary Long Term Care Formulary Pharmacy & Therapeutics Highlights https://www.albertahealthservices.ca/info/page4071.aspx Page 2 of 14 Contents... 3 Formulary Changes (Additions, Changes,
More informationPublic Assessment Report. Mebeverine hydrochloride 50mg/5ml Oral Suspension. (Mebeverine hydrochloride) UK Licence No: PL 44710/0024
Public Assessment Report Mebeverine hydrochloride 50mg/5ml Oral Suspension (Mebeverine hydrochloride) UK Licence No: PL 44710/0024 Kinedexe UK Limited 1 LAY SUMMARY Mebeverine hydrochloride 50mg/5ml Oral
More informationDINABANDHU ANDREWS COLLEGE GARIA, KOLKATA Tender Notice
DINABANDHU ANDREWS COLLEGE GARIA, KOLKATA-700084 DEPARTMENT OF BOTANY Tender Notice DAC/NIT-2/2017-18 dated 07.04.2017 Sealed quotations are invited from reputed agencies/companies/concern in connection
More informationOTCPharm FY/Q sales results
OTCPharm FY/Q4 2014 sales results Olga Mednikova, CEO Irina Bakhturina, Head of Investor Relations February, 2015 Russia Pharma Market Update In 2014, Russian commercial OTC market grew by 9.5% y-o-y reaching
More informationSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT Poliomyelitis Vaccine, Live (Oral) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.1 ml = 2 drops contains: Polio Virus Type 1 (Sabin strain) Not less than 10
More informationFLUIMUKAN PLUS 600 mg effervescent tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER FLUIMUKAN PLUS 600 mg effervescent tablets Acetylcysteine This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for
More informationClass I Drugs Event Event ID: Product Type: Status: Date Terminated: Recall Initiation Date: Voluntary / Mandated: Center Classification Date:
Class I Event 76678 12/29/2015 06/13/2017 E-Mail Complete Pharmacy and Medical Solutions LLC 5829 Nw 158th St Miami Lakes FL United States Distributed throughout Florida Human Chorionic Gonadotropin, 125
More information